Articles
-
Diet and Breast Cancer, Myths and Uncertainties
No area of oncology is more complex and controversial than the relationship of cancer and diet. Everyone would like to believe that there is some diet which can substantially affect the likelihood of cancer, or better still to cure it once contracted. But to date, the evidence of the effect of diet is unclear and often inconsistent.
-
Environmental and Lifestyle Risks Of Breast Cancer
Though still an area of active research, many lifestyle and environmental risk factors for breast cancer have been identified. Fortunately, almost all of them are controllable by an individual seeking to optimize his or her health. Yes, men get breast cancer, too, at about 1/133 the rate of women.
-
Genetic Risks Of Breast Cancer
According to official figures, only between 5-10% of breast cancer is caused by genetic influences. But even though the percentage is relatively low, the numbers are high enough to warrant many women and men seeking regular checkups. Yes, men get breast cancer, too. Only about 0.7% as often as women, but it does occur, killing about 12,000 men per year.
-
How Is Breast Cancer Diagnosed?
Medical professionals now have an extensive array of tools at their disposal to make diagnosis of breast cancer more reliable, especially in the early stages. That's great news, since it considerably increases the odds of keeping breast cancer down to the level of 'serious but not permanently scarring or life-threatening'.
-
Breast Cancer - No Longer A Killer
Breast cancer remains a serious condition, affecting one in twelve women sometime in their lifetime. But, fortunately, it is no longer typically life threatening or permanently scarring.
Headlines
-
Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer - Forbes
Cell Genesys, Inc. (Nasdaq:CEGE) today announced that it has terminated VITAL-2, the second of two Phase 3 clinical trials of GVAX immunotherapy for prostate cancer, which compares GVAX immunotherapy in combination with Taxotere(R) (docetaxel) to
-
E! Standing Up To Cancer Too - Broadcasting Cable
E! Entertainment Television will join NBC, CBS and ABC in televising the cross network âStand Up To Cancerâ fundraising special. The one hour, commercial free special will be simulcast on the networks at 8 p.m. Friday, September 5. E! will also
-
Shanteau undergoes cancer surgery - Washington Post
ATLANTA -- Eric Shanteau had surgery Wednesday to remove a cancerous testicle after fulfilling his goal of swimming in the Olympics. The 24-year-old breaststroker underwent the operation at Emory University Hospital, said his agent, Evan Morgenstein
-
Stent Probe Undermines J&J, Abbott, Boston Scientific Target - Bloomberg
Aug. 28 (Bloomberg) -- A $1.8 billion market for metal tubes used to clear blocked arteries outside the heart may be upended by a U.S. probe into marketing practices by Johnson & Johnson , Boston Scientific Corp. and Abbott Laboratories. The Food and
-
Pro-Pharmaceuticals gets an FDA OK - Boston Globe
Pro-Pharmaceuticals Inc. of Newton said today that the US Food and Drug Administration has granted it an approval to use Davanat in a potential treatment for breast cancer patients. Specifically, the FDA granted the company an investigational new
